FDA

The FDA and CDC were seeing much of the same data, but as regulatory agencies, they were more cautious.

With an increasing number of hearing aids being sold directly to consumers, advocates are eager for the FDA rules to...

Thousands of people have rushed to receive infusions of powerful antibody cocktails shown to reduce hospitalizations by 70% when given...

White House officials emphasized that the rollout of boosters was pending review of evidence by the FDA and the CDC....

Do you or someone you know have a pacemaker, defibrillator, implanted prosthetic, or other lifesaving device? Do you work with...

Inspectors repeatedly found manufacturing and device quality problems with the HeartWare heart pump. But the FDA did not penalize the...

We wanted to know whether there was any truth to the idea that the CDC was removing its test because...

The drugmaker is running an educational campaign directed at the consumer, one who is already worried about whether those lost...

Ultimately, the question of whether a booster is needed is unlikely to determine the FDA?s decision.

Getting expanded access to unproven therapies for rare diseases is more difficult than for more common illnesses, such as cancer.

Academic air quality experts say the technology can be ineffective or potentially create harmful byproducts.

Though patients will start taking it, the world may have to wait many years to find out whether Aduhelm is...